Who Exports Nitroglycerin from India — 191 Suppliers Behind a $9.7M Market
India's nitroglycerin export market is supplied by 191 active exporters who collectively shipped $9.7M across 1,254 shipments. RUBICON RESEARCH PRIVATE LIMITED leads with a 26.6% market share, followed by TROIKAA PHARMACEUTICALS LIMITED and BHARAT EXPLOSIVES LIMITED. The top 5 suppliers together control 68.1% of total export value, reflecting a concentrated market structure.
Top Nitroglycerin Exporters from India — Ranked by Export Value
RUBICON RESEARCH PRIVATE LIMITED is the leading nitroglycerin exporter from India, holding a 26.6% share of the $9.7M market across 1,254 shipments from 191 exporters. The top 5 suppliers — RUBICON RESEARCH PRIVATE LIMITED, TROIKAA PHARMACEUTICALS LIMITED, BHARAT EXPLOSIVES LIMITED, MANKIND PHARMA LIMITED, NATCO PHARMA LIMITED — collectively control 68.1% of total export value, indicating a moderately concentrated market. Individual shares are: RUBICON RESEARCH PRIVATE LIMITED (26.6%), TROIKAA PHARMACEUTICALS LIMITED (18.0%), BHARAT EXPLOSIVES LIMITED (8.4%), MANKIND PHARMA LIMITED (7.5%), NATCO PHARMA LIMITED (7.5%).
Top Nitroglycerin Exporters from India
Ranked by export value · 191 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | RUBICON RESEARCH PRIVATE LIMITED NITROGLYCERIN SUBLING TAB 0.4MG 4X25 | $2.6M | 1 | 26.6% |
| 2 | TROIKAA PHARMACEUTICALS LIMITED MYONIT INSTA NITROGLYCERIN SUBLINGUAL TA | $1.7M | 8 | 18.0% |
| 3 | BHARAT EXPLOSIVES LIMITED MYONIT INSTA NITROGLYCERIN SUBLINGUAL TADILUTED NITROGLYCERIN USP (TAX INVOICE N | $814.3K | 5 | 8.4% |
| 4 | MANKIND PHARMA LIMITED NITROGLYCERIN SUBLING TAB 0.4MG 4X25 | $728.5K | 1 | 7.5% |
| 5 | NATCO PHARMA LIMITED NITROGLYCERIN SUBLING TAB 0.4MG 4X25 | $725.3K | 1 | 7.5% |
| 6 | GLENMARK PHARMACEUTICALS LIMITED NITROGLYCERIN SUBLING TAB 0.4MG 4X25 | $451.0K | 1 | 4.7% |
| 7 | UNITED BIOTECH PRIVATE LIMITED NITROSHOK NITROGLYCERIN INJECTION 25MG/5MLNITROCONTIN 6.4 MG TABLET BOTTLE OF 25 SNITROSHOK,NITROGLYCERIN INJECTION 25MG/5 | $213.7K | 7 | 2.2% |
| 8 | GLENMARK PHARMACEUTICALS LTD NITROGLYCERIN SUBLING TAB 0.4MG 4X25 | $182.6K | 1 | 1.9% |
| 9 | CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED NITROSHOK NITROGLYCERIN INJECTION 25MG/5MLNITROSHOK,NITROGLYCERIN INJECTION 25MG/5NITROGLICERINA | $181.0K | 7 | 1.9% |
| 10 | RUBICON RESEARCH LIMITED NITROGLYCERIN SUBLING TAB 0.4MG 4X25 | $176.4K | 1 | 1.8% |
| 11 | SRS PHARMACEUTICALS PRIVATE LIMITED NITROSAN NITROGLYCERIN 1MG/ML SOLUTION FOR INJECTIONNITROSAN (NITROGLYCERINE 1MG/ML SOLUTIONNITROSAN-NITROGLYCERINE 1MG/ML SOLUTION | $118.7K | 1 | 1.2% |
| 12 | GENEX PHARMA NITROCONTIN 6.4 MG TABLET BOTTLE OF 25 SHARMLESS MEDICINES FOR HUMAN CONSUMPTION- GLYMERC | $106.3K | 10 | 1.1% |
| 13 | CENTURION HEALTHCARE PRIVATE LIMITED NITROCONTIN 6.4 MG TABLET BOTTLE OF 25 SHARMLESS MEDICINES FOR HUMAN CONSUMPTION- GLYMERC | $96.0K | 1 | 1.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Nitroglycerin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Rubicon Research Private Limited | Approved | Unknown | Unknown | 15 | Received FDA approval for Valsartan Oral Solution on June 5, 2025. |
| Glenmark Pharmaceuticals Limited | Warning Letter (July 2025 | Unknown | Unknown | Unknown | FDA issued a warning letter in July 2025 citing inadequate management oversight |
| Ciron Drugs and Pharmaceuticals Private Limited | Unknown | Yes | Unknown | Unknown | Manufacturing facilities certified by WHO-GMP. |
TransData Nexus reviewed the regulatory standing of 3 leading Nitroglycerin exporters from India. 1 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Nitroglycerin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and intermediates. Notable firms include A.R. Life Sciences, which manufactures APIs for various treatments, and Hy-Gro Chemicals, focusing on cost-effective API development. This concentration of bulk drug manufacturers positions Hyderabad as a strategic hub for sourcing nitroglycerin and related compounds.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Vadodara, in particular, is a major hub for pharmaceutical companies, hosting numerous firms involved in the production of formulations and biogenerics. Companies like Alembic Pharmaceuticals, headquartered in Vadodara, manufacture and market a range of pharmaceutical products, including APIs and formulations. This region's focus on formulations makes it a key area for sourcing finished nitroglycerin products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to global markets. Companies like Formel Labs, with facilities in Mumbai and Hyderabad, specialize in producing high-quality APIs and formulations, ensuring compliance with international standards. This region's infrastructure and proximity to ports make it advantageous for exporting nitroglycerin products.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, primarily due to favorable tax incentives. This area hosts numerous pharmaceutical companies engaged in the production of various formulations. While not a primary center for nitroglycerin production, the region's cost advantages and manufacturing capabilities make it a potential area for sourcing related pharmaceutical products.
5Sourcing Recommendations
- Leverage Hyderabad's API Production: Engage with Hyderabad-based manufacturers like A.R. Life Sciences and Hy-Gro Chemicals for sourcing high-quality nitroglycerin APIs, benefiting from the region's extensive bulk drug production capabilities.
- Utilize Gujarat's Formulation Expertise: Collaborate with companies in the Ahmedabad-Vadodara corridor, such as Alembic Pharmaceuticals, to access finished nitroglycerin formulations, taking advantage of the region's specialization in pharmaceutical formulations.
- Optimize Export Logistics via Mumbai: Partner with firms like Formel Labs in the Mumbai-Thane-Raigad region to streamline the export process, leveraging the area's robust infrastructure and proximity to major ports.
- Consider Cost Benefits in Baddi-Nalagarh: Explore manufacturing partnerships in the Baddi-Nalagarh tax incentive zone to potentially reduce production costs for nitroglycerin-related products.
By strategically engaging with these pharmaceutical clusters, companies can effectively source nitroglycerin and related products, ensuring quality, cost-efficiency, and compliance with international standards.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Nitroglycerin exporters from India
Rubicon Research Private Limited — Rubicon Research acquires Alkem's Pithampur manufacturing site
Rubicon Research expanded its manufacturing capabilities by acquiring Alkem's Pithampur facility, enhancing its production capacity for various pharmaceutical products. - IMPACT: This acquisition is expected to bolster Rubicon's nitroglycerin production capacity, potentially increasing export volumes.
Impact: This acquisition is expected to bolster Rubicon's nitroglycerin production capacity, potentially increasing export volumes.
Mankind Pharma Limited — CDSCO flags Mankind Pharma's Rabeprazole tablets as substandard
The Central Drugs Standard Control Organisation (CDSCO) identified Mankind Pharma's Rabeprazole Gastro Resistant Tablets as not meeting quality standards during routine testing. - IMPACT: While this pertains to a different product, such regulatory scrutiny may prompt Mankind Pharma to enhance quality controls across all products, including nitroglycerin, potentially affecting export reliability.
Impact: While this pertains to a different product, such regulatory scrutiny may prompt Mankind Pharma to enhance quality controls across all products, including nitroglycerin, potentially affecting export reliability.
Rubicon Research Private Limited — Rubicon Research acquires Validus Pharmaceuticals
Rubicon Research expanded its U.S. presence by acquiring Validus Pharmaceuticals, a provider of logistic services to pharmaceutical companies. - IMPACT: This acquisition may enhance Rubicon's distribution capabilities for nitroglycerin in the U.S. market, potentially increasing export volumes.
Impact: This acquisition may enhance Rubicon's distribution capabilities for nitroglycerin in the U.S. market, potentially increasing export volumes.
Common Questions — Nitroglycerin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which nitroglycerin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, RUBICON RESEARCH PRIVATE LIMITED leads with 92 recorded shipments worth $2.6M. TROIKAA PHARMACEUTICALS LIMITED (26 shipments) and BHARAT EXPLOSIVES LIMITED (47 shipments) are also established high-volume exporters.
Q How many nitroglycerin manufacturers are there in India?
India has 191 active nitroglycerin exporters with a combined export market of $9.7M across 1,254 shipments to 102 countries. The top 5 suppliers hold 68.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for nitroglycerin from India?
Average FOB unit price: $25.48 per unit, ranging from $0.01 to $1308.45. Average shipment value: $7.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 191 verified Indian exporters of Nitroglycerin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,254 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 102 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,254 Verified Shipments
191 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists